A six-gene-based prognostic signature for hepatocellular carcinoma overall survival prediction

2018/04/17 by Zhenglu Wang, Dahong Teng, Yan Li +3 · 25 citations
Medicine · #Ferroptosis and cancer prognosis #Hepatocellular Carcinoma Treatment and Prognosis #Cancer Mechanisms and Therapy

paper · doi:10.1016/j.lfs.2018.04.025

Cited by

• Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma. [europepmc]
• Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma. [europepmc]
• Identification and validation of a prognostic four-genes signature for hepatocellular carcinoma: integrated ceRNA network analysis. [europepmc]
• Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma. [europepmc]
• Six-gene-based prognostic model predicts overall survival in patients with uveal melanoma. [europepmc]
• Identification of Platform-Independent Diagnostic Biomarker Panel for Hepatocellular Carcinoma Using Large-Scale Transcriptomics Data. [europepmc]
• An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma. [europepmc]
• Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma. [europepmc]
• A Nomogram Based on a Three-Gene Signature Derived from AATF Coexpressed Genes Predicts Overall Survival of Hepatocellular Carcinoma Patients. [europepmc]
• A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma. [europepmc]
• A Novel Ten-Gene Signature Predicting Prognosis in Hepatocellular Carcinoma. [europepmc]
• Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature. [europepmc]
• Development and validation of a RNA binding protein gene pair-associated prognostic signature for prediction of overall survival in hepatocellular carcinoma. [europepmc]
• Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma. [europepmc]
• Development and validation of a novel pseudogene pair-based prognostic signature for prediction of overall survival in patients with hepatocellular carcinoma. [europepmc]
• A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients. [europepmc]
• Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma. [europepmc]
• Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke. [europepmc]
• Co-amplification of genes in chromosome 8q24: a robust prognostic marker in hepatocellular carcinoma. [europepmc]
• Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma. [europepmc]
• Transcriptomic profiling of peroxisome-related genes reveals a novel prognostic signature in hepatocellular carcinoma. [europepmc]
• Gene signature to predict prognostic survival of hepatocellular carcinoma. [europepmc]
• WGCNA, LASSO and SVM Algorithm Revealed RAC1 Correlated M0 Macrophage and the Risk Score to Predict the Survival of Hepatocellular Carcinoma Patients. [europepmc]
• A Novel Gene Pair CSTF2/DPE2A Impacts Prognosis and Cell Cycle of Hepatocellular Carcinoma. [europepmc]
• M6A-methylated circPOLR2B forms an R-loop and regulates the biological behavior of glioma stem cells through positive feedback loops. [europepmc]